Literature DB >> 16938406

C57BL/6J mice exhibit reduced dopamine D3 receptor-mediated locomotor-inhibitory function relative to DBA/2J mice.

R K McNamara1, B Levant, B Taylor, R Ahlbrand, Y Liu, J R Sullivan, K Stanford, N M Richtand.   

Abstract

Previous reports have identified greater sensitivity to the locomotor-stimulating, sensitizing, and reinforcing effects of amphetamine in inbred C57BL/6J mice relative to inbred DBA/2J mice. The dopamine D3 receptor (D3R) plays an inhibitory role in the regulation of rodent locomotor activity, and exerts inhibitory opposition to D1 receptor (D1R)-mediated signaling. Based on these observations, we investigated D3R expression and D3R-mediated locomotor-inhibitory function, as well as D1R binding and D1R-mediated locomotor-stimulating function, in C57BL/6J and DBA/2J mice. C57BL/6J mice exhibited lower D3R binding density (-32%) in the ventral striatum (nucleus accumbens/islands of Calleja), lower D3R mRNA expression (-26%) in the substantia nigra/ventral tegmentum, and greater D3R mRNA expression (+40%) in the hippocampus, relative to DBA/2J mice. There were no strain differences in DR3 mRNA expression in the ventral striatum or prefrontal cortex, nor were there differences in D1R binding in the ventral striatum. Behaviorally, C57BL/6J mice were less sensitive to the locomotor-inhibitory effect of the D3R agonist PD128907 (10 microg/kg), and more sensitive to the locomotor-stimulating effects of novelty, amphetamine (1 mg/kg), and the D1R-like agonist +/- -1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8,-diol hydrochloride (SKF38393) (5-20 mg/kg) than DBA/2J mice. While the selective D3R antagonist N-(4-[4-{2,3-dichlorphenyl}-1 piperazinyl]butyl)-2-fluorenylcarboxamide (NGB 2904) (0.01-1.0 mg/kg) augmented novelty-, amphetamine-, and SKF38393-induced locomotor activity in DBA/2J mice, it reduced novelty-induced locomotor activity in C57BL/6J mice. Collectively, these results demonstrate that C57BL/6J mice exhibit less D3R-mediated inhibitory function relative to DBA/2J mice, and suggest that reduced D3R-mediated inhibitory function may contribute to heightened sensitivity to the locomotor-stimulating effects of amphetamine in the C57BL/6J mouse strain. Furthermore, these data demonstrate that comparisons between C57BL/6J and DBA/2J mouse strains provide a model for elucidating the molecular determinants of genetic influence on D3R function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938406      PMCID: PMC1815378          DOI: 10.1016/j.neuroscience.2006.07.015

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  67 in total

1.  Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses.

Authors:  A Zapata; J M Witkin; T S Shippenberg
Journal:  Neuropharmacology       Date:  2001-09       Impact factor: 5.250

2.  Intra-accumbens infusion of D(3) receptor agonists reduces spontaneous and dopamine-induced locomotion.

Authors:  A M Ouagazzal; I Creese
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

3.  Enhanced cleavage of an atypical intron of dopamine D3-receptor pre-mRNA in chronic schizophrenia.

Authors:  C Schmauss
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

4.  Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors.

Authors:  M Xu; T E Koeltzow; G T Santiago; R Moratalla; D C Cooper; X T Hu; N M White; A M Graybiel; F J White; S Tonegawa
Journal:  Neuron       Date:  1997-10       Impact factor: 17.173

5.  Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice.

Authors:  C J Meliska; A Bartke; G McGlacken; R A Jensen
Journal:  Pharmacol Biochem Behav       Date:  1995-04       Impact factor: 3.533

6.  Genetic control of dopamine and serotonin receptors in brain regions of inbred mice.

Authors:  R E Boehme; R D Ciaranello
Journal:  Brain Res       Date:  1983-04-25       Impact factor: 3.252

7.  In vivo evidence that genetic background controls impulse-dependent dopamine release induced by amphetamine in the nucleus accumbens.

Authors:  Rossella Ventura; Antonio Alcaro; Laura Mandolesi; Stefano Puglisi-Allegra
Journal:  J Neurochem       Date:  2004-04       Impact factor: 5.372

8.  Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain.

Authors:  T Kling-Petersen; E Ljung; K Svensson
Journal:  J Neural Transm Gen Sect       Date:  1995

9.  7-OH-DPAT and PD 128907 selectively activate the D3 dopamine receptor in a novel environment.

Authors:  Laurel M Pritchard; Aaron D Logue; Scott Hayes; Jeffrey A Welge; Ming Xu; Jianhua Zhang; S Paul Berger; Neil M Richtand
Journal:  Neuropsychopharmacology       Date:  2003-01       Impact factor: 7.853

10.  Distinct patterns of Fos expression induced by systemic amphetamine in the striatal complex of C57BL/6JICo and DBA/2JICo inbred strains of mice.

Authors:  D Conversi; C Orsini; S Cabib
Journal:  Brain Res       Date:  2004-10-29       Impact factor: 3.252

View more
  19 in total

1.  Dopaminergic reward system: a short integrative review.

Authors:  Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal:  Int Arch Med       Date:  2010-10-06

2.  Comparison of the performance of DBA/2 and C57BL/6 mice in transitive inference and foreground and background contextual fear conditioning.

Authors:  Jessica M André; Kristy A Cordero; Thomas J Gould
Journal:  Behav Neurosci       Date:  2012-02-06       Impact factor: 1.912

3.  Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expression.

Authors:  Neil M Richtand; Yanhong Liu; Rebecca Ahlbrand; Juliana R Sullivan; Amy Hauck Newman; Robert K McNamara
Journal:  Synapse       Date:  2010-08       Impact factor: 2.562

4.  The effects of pramipexole on prepulse inhibition and locomotor activity in C57BL/6J mice.

Authors:  Wei-Li Chang; Mark A Geyer; Mahalah R Buell; Martin Weber; Neal R Swerdlow
Journal:  Behav Pharmacol       Date:  2010-03       Impact factor: 2.293

5.  Omega-3 fatty acid deficiency during perinatal development increases serotonin turnover in the prefrontal cortex and decreases midbrain tryptophan hydroxylase-2 expression in adult female rats: dissociation from estrogenic effects.

Authors:  Robert K McNamara; Jessica Able; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso; Jack W Lipton
Journal:  J Psychiatr Res       Date:  2008-11-04       Impact factor: 4.791

Review 6.  Does the difference between physically active and couch potato lie in the dopamine system?

Authors:  Amy M Knab; J Timothy Lightfoot
Journal:  Int J Biol Sci       Date:  2010-03-09       Impact factor: 6.580

7.  Motivational effects of opiates in conditioned place preference and aversion paradigm--a study in three inbred strains of mice.

Authors:  Wojciech Solecki; Anna Turek; Jakub Kubik; Ryszard Przewlocki
Journal:  Psychopharmacology (Berl)       Date:  2009-09-29       Impact factor: 4.530

8.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

9.  The aging human orbitofrontal cortex: decreasing polyunsaturated fatty acid composition and associated increases in lipogenic gene expression and stearoyl-CoA desaturase activity.

Authors:  Robert K McNamara; Yanhong Liu; Ronald Jandacek; Therese Rider; Patrick Tso
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2008-05-21       Impact factor: 4.006

10.  Are DBA/2 mice associated with schizophrenia-like endophenotypes? A behavioural contrast with C57BL/6 mice.

Authors:  Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2009-05-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.